CSIG-09. ERK1/2-DRIVEN SPROUTY2 EXPRESSION MEDIATES RESISTANCE TO RECEPTOR TYROSINE KINASE-TARGETED THERAPEUTICS IN GLIOBLASTOMA CELLS
Author(s) -
Evan K. Day,
Matthew J. Lazzara
Publication year - 2016
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/now212.170
Subject(s) - receptor tyrosine kinase , cancer research , mapk/erk pathway , kinase , biology , signal transduction , phosphorylation , carcinogenesis , microbiology and biotechnology , cancer , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom